FDA Accepts New Drug Application for INSYS Therapeutics' Naloxo...

07/03/19

FDA Accepts New Drug Application for INSYS Therapeutics' Naloxone Nasal Spray for the Emergency Treatment of Known or Suspected Opioid Overdose  GlobeNewswire

PHOENIX, July 03, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (OTCMKTS: INSYQ), announced today that its New Drug Application (NDA) to the ...

[more]